Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit

Activation of the type 1 interferon (T1 IFN) pathway has been implicated in the pathogenesis of systemic sclerosis (SSc) by an increasing number of studies, most of which share key findings with similar studies in systemic lupus erythematosus (SLE). Here we will focus on the evidence for T1 IFN acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakkar, Vishal, Assassi, Shervin, Allanore, Yannick, Kuwana, Masataka, Denton, Christopher P., Khanna, Dinesh, Del Galdo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
RAYNAUD PHENOMENON, SCLERODERMA, OVERLAP SYNDROMES AND OTHER FIBROSING SYNDROMES: Edited by Shervin Assassi
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594133/
https://www.ncbi.nlm.nih.gov/pubmed/36125916
http://dx.doi.org/10.1097/BOR.0000000000000907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594133/
https://www.ncbi.nlm.nih.gov/pubmed/36125916
http://dx.doi.org/10.1097/BOR.0000000000000907

Ejemplares similares